Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Abstract

This research paper explore the methodology and findings associated with The Lancet Oncology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now